Important Aligos Phase 2 B-SUPREME Study Progress Revealed
Aligos has enrolled 144 patients into its Phase 2 B-SUPREME study of pevifoscorvir sodium (ALG-000184) in chronic hepatitis B,...
eClinical Tech News
Comphya CaverSTIM Study Published in BJUI, Nature Urology
In a first-in-human pilot of 10 preoperatively potent men undergoing nerve‑sparing robotic radical prostatectomy, Comphya’s implantable cavernous nerve neurostimulator...
Nxera Pharma Reports Successful Daridorexant Phase 3 Trial
Daridorexant 50 mg met the primary endpoint of change from baseline in subjective total sleep time at Day 28...
BioAge Announces Promising New Trial for Macular Edema Drug
In preclinical models of diabetic macular edema, oral BGE-102 nearly eliminated retinal vascular leakage and preserved up to 90%...
Tiziana Life Sciences Publishes Intranasal Foralumab Study
In an open-label study of 10 patients with non-active secondary progressive multiple sclerosis, intranasal foralumab showed no serious or...
Clinical Trial Tests D-Serine to Modify Parkinson’s Disease
SPARK NS and Haukeland University Hospital will run a randomized, double-blind, placebo-controlled Phase 2b trial of oral D-serine in...
Reunion Unlocks Full RE104 PPD Phase 2 Trial Results
Reunion Neuroscience’s single-dose RE104 met the primary endpoint in the Phase 2 RECONNECT study for postpartum depression (PPD), delivering...
Axsome Launches Surging Phase 3 Trial for Fibromyalgia Drug
Axsome has dosed the first patient in FORWARD, a Phase 3 randomized withdrawal trial of AXS-14 (esreboxetine) for fibromyalgia....
Pioneering Phase 3 Prostate Cancer Study Doses First Patient
Telix has dosed the first U.S. patient in BiPASS, a prospective, open-label Phase 3 study evaluating whether adding 68Ga-PSMA-11...
COACH Trial Confirms Durable Benefits in Achondroplasia
Topline at 52 weeks from Ascendis’ Phase 2 COACH study in pediatric achondroplasia showed mean annualized growth velocity of...